TROCOXIL 30 MG CHEWABLE TABLETS VETERINARY

País: Israel

Idioma: anglès

Font: Ministry of Health

ingredients actius:

MAVACOXIB

Disponible des:

ZOETIS ISRAEL HOLDING B.V., ISRAEL

formulario farmacéutico:

CHEWABLE TABLETS

Composición:

MAVACOXIB 30 MG

Vía de administración:

PER OS

tipo de receta:

Required

Fabricat per:

PFIZER ITALIA S.R.L., ITALY

indicaciones terapéuticas:

For the treatment of pain and inflammation associated with degenerative joint disease in dogs in cases where continuous treatment exceeding one month is indicated

Data d'autorització:

2018-06-30

Informació per a l'usuari

1
Trocoxil LPD 14.10.2021
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Trocoxil 20 mg Chewable Tablets Veterinary
Trocoxil 30 mg Chewable Tablets Veterinary
Trocoxil 75 mg Chewable Tablets Veterinary
Trocoxil 95 mg Chewable Tablets Veterinary
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each chewable tablet contains:
ACTIVE SUBSTANCE:
Mavacoxib
20 mg
Mavacoxib
30 mg
Mavacoxib
75 mg
Mavacoxib
95 mg
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Chewable tablets
Triangular tablet with mottled brown appearance embossed with the
tablet strength on one side.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs aged 12 months or more.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of pain and inflammation associated with
degenerative joint disease in dogs in cases
where continuous treatment exceeding one month is indicated.
4.3
CONTRAINDICATIONS
Do not use in dogs less than 12 months of age and/or less than 7 kg
body weight
Do not use in dogs suffering from gastro-intestinal disorders
including ulceration and bleeding.
Do not use where there is evidence of a haemorrhagic disorder.
Do not use in cases of impaired renal or hepatic function
Do not use in cases of cardiac insufficiency
Do not use in pregnant, breeding or lactating dogs.
Do not use in case of hypersensitivity to the active substance or to
any of the excipients
Do not use in cases of known hypersensitivity to sulphonamides.
Do not use concomitantly with glucocorticoids or other Non-Steroidal
Anti-Inflammatory Drugs
(NSAIDs), see section 4.8.
Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as
there is a potential risk of increased
renal toxicity.
2
Trocoxil LPD 14.10.2021
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Do not administer other NSAIDs or glucocorticoids concurrently or
within 1 month of the last
administration of Trocoxil.
4.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
Mavacoxib exhibits an extended plasma half life (up to > 80 days, see
section 5.2) due to its l